| 000 | 01877 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514160232.0 | ||
| 264 | 0 | _c20040224 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a0013-7227 | ||
| 024 | 7 |
_a10.1210/en.2003-1070 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLopez-Talavera, Juan Carlos | |
| 245 | 0 | 0 |
_aHepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. _h[electronic resource] |
| 260 |
_bEndocrinology _cFeb 2004 |
||
| 300 |
_a467-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 |
_aHepatocyte Growth Factor _xgenetics |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
| 650 | 0 | 4 |
_aIslets of Langerhans Transplantation _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aPortal Vein |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Lew |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aGarcia-Ocaña, Adolfo | |
| 700 | 1 | _aSipula, Ian | |
| 700 | 1 | _aTakane, Karen K | |
| 700 | 1 | _aCozar-Castellano, Irene | |
| 700 | 1 | _aStewart, Andrew F | |
| 773 | 0 |
_tEndocrinology _gvol. 145 _gno. 2 _gp. 467-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/en.2003-1070 _zAvailable from publisher's website |
| 999 |
_c14296564 _d14296564 |
||